Open access
65
Views
1
CrossRef citations to date
0
Altmetric
Review
Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review
Hai Bo Haber Xue1 Lilly Suzhou Pharmaceutical Co, Ltd, Shanghai Branch, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
, Li Liu1 Lilly Suzhou Pharmaceutical Co, Ltd, Shanghai Branch, Shanghai, People’s Republic of China
, Hena Zhang2 China Pharmaceutical University, Nanjing, People’s Republic of China
, William Montgomery3 Eli Lilly Australia Pty Ltd, West Ryde, Australia
& Tamás Treuer4 Eli Lilly & Co, Budapest, Hungary
Pages 841-864
|
Published online: 16 May 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.